Litcius/Paper detail

Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease

Chae Kim, Tracy Haldiman, Sang‐Gyun Kang, Lenka Hromádková, Zhuang Zhuang Han, Wei Chen, Frances Lissemore, Alan J. Lerner, Rohan de Silva, Mark L. Cohen, David Westaway, Jiri Safar

2022Science Translational Medicine60 citationsDOIOpen Access PDF

Abstract

Although genetic factors play a main role in determining the risk of developing Alzheimer’s disease (AD), they do not explain extensive spectrum of clinicopathological phenotypes. Deposits of aggregated TAU proteins are one of the main predictors of cognitive decline in AD. We investigated the hypothesis that variabilities in AD progression could be due to diverse structural assemblies (strains) of TAU protein. Using sensitive biophysical methods in 40 patients with AD and markedly different disease durations, we identified populations of distinct TAU particles that differed in size, structural organization, and replication rate in vitro and in cell assay. The rapidly replicating, distinctly misfolded TAU conformers found in rapidly progressive AD were composed of ~80% misfolded four-repeat (4R) TAU and ~20% of misfolded 3R TAU isoform with the same conformational signatures. These biophysical observations suggest that distinctly misfolded population of 4R TAU conformers drive the rapid decline in AD and imply that effective therapeutic strategies might need to consider not a singular species but a cloud of differently misfolded TAU conformers.

Topics & Concepts

Conformational isomerismDiseaseProtein foldingPopulationTau proteinPhenotypeBiologyCognitive declineAlzheimer's diseaseChemistryCell biologyEvolutionary biologyNeuroscienceGeneticsMedicineDementiaPathologyGeneMoleculeEnvironmental healthOrganic chemistryPrion Diseases and Protein MisfoldingAlzheimer's disease research and treatments14-3-3 protein interactions
Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease | Litcius